16 December 2016
ASX Announcements Office Exchange Centre
20 Bridge Street
SYDNEY NSW 2000
APPENDIX 3B & SECTION 708A NOTICEAn Appendix 3B for the issue of 5,250,000 Shares on conversion of Unlisted Options is attached.
The Company gives notice pursuant to Section 708A(5)(e) of the Corporations Act that the Shares issued were issued without disclosure under Part 6D.2, in reliance on Section 708A(5) of the Corporations Act. The Company, as at the date of this notice, has complied with the provisions of Chapter 2M of the Corporations Act as they apply to the Company and Section 674 of the Corporations Act. There is no excluded information to be disclosed for the purposes of Sections 708A(7) and (8) of the Corporations Act.
Yours faithfully
Nicki Farley Company Secretary
ResApp Health Limited ABN 51 094 468 318
Level 24, 44 St Georges Tce, Perth WA 6000
T +61 8 6211 5099 E info@resapphealth.com.au W www.resapphealth.com.au
Appendix 3BRule 2.7, 3.10.3, 3.10.4, 3.10.5
New issue announcement, application for quotation of additional securities and agreementInformation or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity |
RESAPP HEALTH LIMITED |
ABN |
51 094 468 318 |
We (the entity) give ASX the following information.
Part 1 - All issuesYou must complete the relevant sections (attach sheets if there is not enough space).
1 | +Class of +securities issued or to be issued | Ordinary Fully Paid Shares |
2 | Number of +securities issued or to be issued (if known) or maximum number which may be issued | 5,250,000 Shares |
3 | Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) | 2,437,500 Shares 2,812,500 Shares (escrowed until 14 July 2017) |
4 | Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state:
| Yes |
5 | Issue price or consideration | Shares issued on conversion of unlisted options at $0.026 per share. |
6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) | Shares issued on exercise of unlisted options. |
6a | Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i | Yes |
6b | The date the security holder resolution under rule 7.1A was passed | 2 November 2016 |
6c | Number of +securities issued without security holder approval under rule 7.1 | Nil |
+ See chapter 19 for defined terms.
Appendix 3B Page 2 04/03/2013
6d | Number of +securities issued with security holder approval under rule 7.1A | Nil | |
6e | Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) | Nil | |
6f | Number of +securities issued under an exception in rule 7.2 | 5,250,000 Shares | |
6g | If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. | Not applicable | |
6h | If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements | Not applicable | |
6i | Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements | Listing Rule 7.1 - 98,855,940 Listing Rule 7.1A - 65,903,960 | |
7 | +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. | 16 December 2016 | |
Number | +Class | ||
8 | Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable) | 596,602,103 | Fully paid ordinary shares |
ResApp Health Limited published this content on 16 December 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 16 December 2016 06:33:07 UTC.
Original documenthttp://www.resapphealth.com.au/wp-content/uploads/2016/12/1629549.pdf
Public permalinkhttp://www.publicnow.com/view/648BF0CDEEDE3FD2CBF02D936744BDC2E7D19DFD